Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial

Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial

Abstract Background Use of inhaled corticosteroids (ICS) increases the risk of pneumonia in chronic obstructive pulmonary disease (COPD), but the magnitude of risk with different ICS remains unclear. Methods A post hoc analysis of the 4-year UPLIFT® trial to assess whether pneumonia risk differed by...

Full description

Bibliographic Details
Main Authors: Donald P. Tashkin, Marc Miravitlles, Bartolomé R. Celli, Norbert Metzdorf, Achim Mueller, David M. G. Halpin, Antonio Anzueto
Format: Article
Language:English
Published: BMC 2018-10-01
Series:Respiratory Research
Subjects:
COPD
Pneumonia
Inhaled corticosteroids
Fluticasone propionate
UPLIFT®
Online Access:http://link.springer.com/article/10.1186/s12931-018-0874-0

Internet

http://link.springer.com/article/10.1186/s12931-018-0874-0

Similar Items